RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM
Clinical trial NCT00805961 · COMPLETED
Trial details
- NCT number
- NCT00805961
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2009-10-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.